Co-Pays for Insulin and Diabetes Medications Capped at $25 in Connecticut

Press release

Co-Pays for Insulin and Diabetes Medications Capped at $25 in Connecticut

The American Diabetes Association® applauds Connecticut’s governor and legislature for passing a cap on co-pays for diabetes medications and supplies

Recently, Connecticut House Bill 6003 was signed into law by Governor Ned Lamont. The law limits cost sharing for insulin and other diabetes medications to $25 per 30-day supply for those with state-regulated commercial health insurance. The law also caps diabetes devices and supplies at $100 per 30-day supply, allows for someone with an expired prescription to obtain insulin in an emergency, and establishes a workgroup on connecting people in need with diabetes medications and care. These measures were supported by the American Diabetes Association (ADA).

Stephen Habbe, Director for State Government Affairs for the ADA, issued the following statement:

“With 357,000 people in Connecticut living with diabetes, and 994,000 with prediabetes, this is one of the most urgent issues for the state. The rising costs of diabetes medications and supplies doesn't help. Insulin prices have skyrocketed, tripling in price between 2002 and 2013 and $3.7 billion health care dollars is spent treating diabetes and its complications in Connecticut. It is critical that elected officials address the needs of their citizens with diabetes. The ADA thanks Governor Ned Lamont, Senator Matt Lesser, Representative Sean Scanlon and the leadership and members of the legislature for passing this bill into law, and for their efforts to address the cost of care and to help those who live with diabetes thrive.”

For more information about the new law, please contact the Connecticut Insurance Department at insurance@ct.gov.

While this law is an important step forward in the fight for affordable care, the ADA recognizes that people with diabetes need relief now more than ever. 

The ADA continues to be the driving force in federal and state efforts to ensure that insulin is affordable and accessible for all people who need it. Take action today at diabetes.org/advocacy/platform.

If you are struggling to pay for insulin or know someone who is, the ADA has resources to help—visit InsulinHelp.org.


# # #
 

Press contacts

About the American Diabetes Association
Every day more than 4,000 people are newly diagnosed with diabetes in America. More than 122 million Americans have diabetes or prediabetes and are striving to manage their lives while living with the disease. The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to bend the curve on the diabetes epidemic and help people living with diabetes thrive. For nearly 80 years the ADA has been driving discovery and research to treat, manage and prevent diabetes, while working relentlessly for a cure. We help people with diabetes thrive by fighting for their rights and developing programs, advocacy and education designed to improve their quality of life. Diabetes has brought us together. What we do next will make us Connected for Life. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (1-800-342-2383). Join the fight with us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn).